Figure 1.
Project protocol for recruitment, screening, and referral and/or counselling of participants according to risk scores.
Risk scores were obtained from the PTASH screening questionnaire and the FlowWizard (as an objective marker of SDB). a Clinical cut-off [22]–[23] RA+ = Risk Assessment Plus, FW = FlowWizard (nasal flow monitor) ESS = Epworth Sleepiness Scale ISI = Insomnia Severity Index MAPI = Multivariate Sleep Apnea Prediction Index RLS = Restless Legs Syndrome Info = provision of sleep disorder specific written information AHI = Apnea Hypopnoea Index PTASH = Pharmacy Tool for Assessment of Sleep Health SDB = sleep disordered breathing.
Figure 2.
CONSORT diagram showing participant flow throughout the study.
a Participants may be classified as at risk of more than one condition. b Comprises n = 76 identified by questionnaire and additional 38 identified by flow monitor AHI≥18 alone in the RA+ group. Comparison between groups: c number at risk of a sleep disorder as identified by pharmacist as a proportion of number screened, OR 3.2, 95% CI 1.7–6.3, p = 0.0009. d follow-up completed as proportion of number screened OR 1.6, 95% CI 0.54–4.5, p = 0.39. e Participants who report being referred as proportion of number referred, in those completing follow-up, OR 1.3, 95% CI 0.69–2.7, p = 0.40. f Participants who report taking up referral (i.e. actually seeing their medical practitioner) as proportion of those referred and completing follow-up, OR 0.65, 95% CI 0.26–1.6, p = 0.31. g Participants diagnosed as proportion of numbers screened, OR 2.7, 95% CI 1.1–7.5, p = 0.03.
Table 1.
General Demographics and Sleep Characteristics in the two groups.
Table 2.
Referral Results and Resulting Diagnoses in the two groups.